We are live on ! Find out more
CPRC

Consolidated Portfolio Review Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 13.59%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+13.59%
3 Year Est. Return
+65.38%
5 Year Est. Return
10 Year Est. Return
AUM
$448M
AUM Growth
+$19.4M
Cap. Flow
-$4.54M
Cap. Flow %
-1.01%
Top 10 Hldgs %
27.06%
Holding
328
New
33
Increased
155
Reduced
98
Closed
19

Top Buys

Rank Stock Value
1
PI icon
Impinj
PI
+$1.46M
2
AVAV icon
AeroVironment
AVAV
+$1.46M
3
AMZN icon
Amazon
AMZN
+$1.39M
4
ASTL icon
Algoma Steel
ASTL
+$1.24M
5
DHI icon
D.R. Horton
DHI
+$1.15M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.07M
2
NU icon
Nu Holdings
NU
+$2.67M
3
MSFT icon
Microsoft
MSFT
+$2.59M
4
EME icon
Emcor
EME
+$2.42M
5
NVDA icon
NVIDIA
NVDA
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 8.18%
2 Financials 2.45%
3 Real Estate 2.3%
4 Consumer Discretionary 2.1%
5 Communication Services 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMCI icon
326
Super Micro Computer
SMCI
$24.3B
-24,300
Closed -$1.99M
VDE icon
327
Vanguard Energy ETF
VDE
$10.4B
-1,696
Closed -$216K
WBA
328
DELISTED
Walgreens Boots Alliance
WBA
-11,600
Closed -$140K

Similar funds

Consolidated Portfolio Review Corp's Q3 2024 Portfolio in Review

As of Q3 2024, Consolidated Portfolio Review Corp held 328 positions worth $448M, up 4.5% from $429M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Consolidated Portfolio Review Corp's Q3 2024 filing shows 33 new, 155 increased, 98 reduced and 19 closed positions. Its largest new stake was Impinj: 8,595 shares worth $1.86M. The largest sale was Eli Lilly, an estimated $4.07M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 10% a quarter earlier, followed by Financials and Real Estate.

  • Consolidated Portfolio Review Corp's largest Q3 2024 buy was Impinj: 8,595 shares worth $1.86M.
  • Consolidated Portfolio Review Corp added most to Amazon in Q3 2024, an estimated $1.39M increase.
  • Consolidated Portfolio Review Corp's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $4.07M.
  • Consolidated Portfolio Review Corp fully exited Nu Holdings in Q3 2024, selling an estimated $2.67M.
  • Consolidated Portfolio Review Corp's ten largest holdings make up 27% of its $448M portfolio in Q3 2024.
  • Consolidated Portfolio Review Corp opened 33 new positions and closed 19 in Q3 2024.
  • Consolidated Portfolio Review Corp's portfolio value rose 4.5% quarter-over-quarter to $448M.

Based on Consolidated Portfolio Review Corp's 13F filing for Q3 2024, filed 24 Oct 2024.